Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 11, 2018, Pages

  Silva, Diego Adão F ^a   Riera, Rachel ^b   Pacheco, Rafael L ^b   Pimentel, Carolina F M G ^a   Gois, Aecio F T ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN;

ACUTE DISEASE; ADVERSE EVENT; BACTERIAL PERITONITIS; BLEEDING TENDENCY; BLOOD TRANSFUSION REACTION; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFICACY; DRUG SAFETY; HEALTH HAZARD; HOSPITALIZATION; HUMAN; HYPOVOLEMIC SHOCK; LENGTH OF STAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY ASPIRATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT FAILURE; UPPER GASTROINTESTINAL BLEEDING;

EID: 85056110748     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD013176     Document Type: Review

References (51)

1. Ananthakrishnan AN, McGinley EL, Saeian K. Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. Clinical Gastroenterology and Hepatology 2007;7:296-302e1.
2. Antunes C, Copelin EL Jr. Gastrointestinal Bleeding, Upper. Treasure Island: StatPearls Publishing, 2017.
3. Bowler WA, Hostettler C, Samuelson D, Lavin BS, Oldfield EC 3rd. Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment. American Journal of Medicine 1992;92(3):249-53.
4. Boyd I. Erythromycin-induced hearing loss. Lancet 1991;337(8733):113.
5. Catnach SM, Fairclough PD. Erythromycin and the gut. Gut 1992;33(3):397-401.
6. Chapman MJ, Fraser RJ, Kluger MT, Buist MD, De Nichilo DJ. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Critical Care Medicine 2000;28:2334-7.
7. Cheng CL, Lee CS, Liu NJ, Chen PC, Chiu CT, Wu CS. Overlooked lesions at emergency endoscopy for acute nonvariceal upper gastrointestinal bleeding. Endoscopy 2002;34(7):527-30.
8. COMET Initiative. Core outcome measures in effectiveness trials initiative. comet-initiative.org (accessed 8 February 2018).
9. Cooper GS, Chak A, Connors AF Jr, Harper DL, Rosenthal GE. The effectiveness of early endoscopy for upper gastrointestinal hemorrhage: a community-based analysis. Medical Care 1998;36:462-74.
10. Cooper GS, Chak A, Way LE, Hammar PJ, Harper DL, Rosenthal GE. Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay. Gastrointestinal Endoscopy 1999;49(2):145-52.
11. de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. Journal of Hepatology 2015;63(3):743-52.
12. Downey KM, Chaput de Saintonge DM. Gastrointestinal side effects after intravenous erythromycin lactobionate. British Journal of Clinical Pharmacology 1986;21(3):295-9.
13. Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointestinal Endoscopy 2008;67(3):422-9.
14. Fallah MA, Prakash C, Edmundowicz S. Acute gastrointestinal bleeding. Medical Clinics of North America 2000;84(5):1183-208.
15. Gholson CF, Warren GH. Fulminant hepatic failure associated with intravenous erythromycin lactobionate. Archives of Internal Medicine 1990;150(1):215-6.
16. Glanzer S, Pulido SA, Tutz S, Wagner GE, Kriechbaum M, Gubensäk N, et al. Structural and functional implications of the interaction between macrolide antibiotics and bile acids. Chemistry 2015;21(11):4350-8.
17. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 15 May 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
18. Haefeli WE, Schoenenberger RA, Weiss P, Ritz R. Possible risk for cardiac arrhythmia related to intravenous erythromycin. Intensive Care Medicine 1992;18:469-73.
19. Hawkyard CV, Koerner RJ. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. Journal of Antimicrobial Chemotherapy 2007;59:347-58.
20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 2003;327(7414):557-60.
21. Higgins JP, Green S, editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
22. Hreinsson JP, Kalaitzakis E, Gudmundsson S, Björnsson ES. Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scandinavian Journal of Gastroenterology 2013;48(4):439-47.
23. Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. American Journal of Physiology 1984;247:G688-94.
24. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. New England Journal of Medicine 1990;322(15):1028-31.
25. Jelić D, Antolović R. From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics 2016;5(3):E29.
26. Josefsson K, Bergan T, Magni L. Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. British Journal of Clinical Pharmacology 1982;13(5):685-91.
27. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence based approach based on meta-analyses of randomized controlled trials. Clinical Gastroenterology and Hepatology 2009;7:33-47.
28. Laine L, Spiegel B, Rostom A, Moayyedi P, Kuipers EJ, Bardou M, et al. Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference. American Journal of Gastroenterology 2010;105(3):540-50.
29. Lanas A, García-Rodríguez LA, Polo-Tomás M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. American Journal of Gastroenterology 2009;104(7):1633-41.
30. Lee SD, Kearney DJ. A randomized controlled trial of gastric lavage prior to endoscopy for acute upper gastrointestinal bleeding. Journal of Clinical Gastroenterology 2004;38(10):861-5.
31. Lyles T, Elliott A, Rockey DC. A risk scoring system to predict in-hospital mortality in patients with cirrhosis presenting with upper gastrointestinal bleeding. Journal of Clinical Gastroenterology 2014;48(8):712-20.
32. MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. Journal of Parenteral and Enteral Nutrition 2008;32(4):412-9.
33. Mantides A, Xynos E, Chrysos E, Georgopoulos N, Vassilakis JS. The effect of erythromycin in gastric emptying of solids and hypertonic liquids in healthy subjects. American Journal of Gastroenterology 1993;88:198-202.
34. McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, et al. Ilotycin, a new antibiotic. Antibiotics & Chemotherapy 1952;2(6):281-3.
35. Nahon S, Hagège H, Latrive JP, Rosa I, Nalet B, Bour B, et al. Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study. Endoscopy 2012;44(11):998-1008.
36. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Critical Care Medicine 2007;35(2):483-9.
37. Oliynyk M, Samborskyy M, Lester JB, Mironenko T, Scott N, Dickens S, et al. Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nature Biotechnology 2007;25(4):447-53.
38. Parsons RL, David JA, Raymond K, Stamp SM. Pharmacokinetics of intravenous erythromycin lactobionate. Journal of International Medical Research 1980;8(Suppl 2):15-23.
39. Pongprasobchai S, Nimitvilai S, Chasawat J, Manatsathit S. Upper gastrointestinal bleeding etiology score for predicting variceal and non-variceal bleeding. World Journal of Gastroenterology 2009;15(9):1099-104.
40. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac causes. New England Journal of Medicine 2004;351(11):1089-96.
41. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
42. Ritz MA, Chapman MJ, Fraser RJ, Finnis ME, Butler RN, Cmielewski P. Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill. Intensive Care Medicine 2005;31:949-54.
43. Sanger GJ. Motilin receptor neuropharmacology: revised understanding. Current Opinion in Pharmacology 2012;12(6):641-6.
44. Sanger GJ, Wang Y, Hobson A, Broad J. Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists. British Journal of Pharmacology 2013;170(7):1323-32.
45. Seifert CF, Swaney RJ, Bellanger-McCleery RA. Intravenous erythromycin lactobionate-induced severe nausea and vomiting. Annals of Pharmacotherapy 1989;23(1):40-4.
46. Stollman NH, Putcha RV, Neustater BR, Tagle M, Raskin JB, Rogers AI. The uncleared fundal pool in acute upper gastrointestinal bleeding: implications and outcomes. Gastrointestinal Endoscopy 1997;46(4):324-7.
47. Tjandramaga TB, Van Hecken A, Mullie A, Verbesselt R, De Schepper PJ, Verbist L, et al. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin. Pharmacology 1984;29(6):305-11.
48. Tzovaras G, Xynos E, Chrysos E, Mantides A, Vassilakis JS. The effect of intravenous erythromycin on esophageal motility in healthy subjects. American Journal of Surgery 1996;171(3):316-9.
49. Urbain JL, Vantrappen G, Janssens J, Van Cutsem E, Peeters T, De Roo M. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. Journal of Nuclear Medicine 1990;31:1490-3.
50. Vale JA, Kulig K, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: gastric lavage. Clinical Toxicology 2004;42(7):933-43.
51. Wysocki JD, Srivastav S, Winstead NS. A nationwide analysis of risk factors for mortality and time to endoscopy in upper gastrointestinal haemorrhage. Alimentary Pharmacology and Therapeutics 2012;36(1):30-6.